Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91689043 | 9168904 | 3 | F | 20160711 | 20130318 | 20160728 | EXP | US-ASTRAZENECA-2013SE16420 | ASTRAZENECA | 81.00 | YR | F | Y | 0.00000 | 20160728 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91689043 | 9168904 | 1 | PS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | U | 0 | TABLET | |||||||||
| 91689043 | 9168904 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | U | 0 | ||||||||||
| 91689043 | 9168904 | 3 | SS | ZESTRIL | LISINOPRIL | 1 | Oral | U | 0 | TABLET | |||||||||
| 91689043 | 9168904 | 4 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | U | 0 | MODIFIED-RELEASE TABLET | |||||||||
| 91689043 | 9168904 | 5 | C | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 91689043 | 9168904 | 6 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 0 | 2 | DF | CAPSULE | BID | |||||||
| 91689043 | 9168904 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | 1 | DF | TABLET | QD | ||||||||
| 91689043 | 9168904 | 8 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 1 TABLET IN THE MORNING AND 2 AT NIGHT | 0 | TABLET | |||||||||
| 91689043 | 9168904 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 0 | 1 | DF | CHEWABLE TABLET | QD | ||||||||
| 91689043 | 9168904 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | 1.0DF UNKNOWN | 0 | 1 | DF | CAPSULE | ||||||||
| 91689043 | 9168904 | 11 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | 0 | .5 | DF | TABLET | QD | ||||||||
| 91689043 | 9168904 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 1 | DF | TABLET | QOD | |||||||
| 91689043 | 9168904 | 13 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 91689043 | 9168904 | 14 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | 0 | 2 | DF | BID | |||||||||
| 91689043 | 9168904 | 15 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 91689043 | 9168904 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 91689043 | 9168904 | Adverse event | |
| 91689043 | 9168904 | Angioedema | |
| 91689043 | 9168904 | Drug hypersensitivity | |
| 91689043 | 9168904 | Dyspnoea | |
| 91689043 | 9168904 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |